Sagimet Biosciences Files Reg FD: Updated Investor Presentation

What Happened

• On July 21, 2026, Sagimet Biosciences, Inc. (SGMT) filed a Current Report on Form 8-K reporting a Regulation FD disclosure. The company attached an updated investor slide presentation dated July 20, 2026 as Exhibit 99.1 and stated company representatives will use this presentation in investor meetings going forward. The presentation is incorporated by reference into the filing.

Key Details

• Filing date: July 21, 2026; presentation date: July 20, 2026.
• SEC Form 8-K items reported: Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Exhibits).
• Exhibit included: 99.1 — Investor Presentation (dated July 20, 2026). Interactive XBRL cover page (Exhibit 104) also filed.
• The filing does not report earnings, executive changes, mergers, or other transactional disclosures.

Why It Matters

• The updated slide deck is now public and is the official presentation Sagimet will use with investors; review Exhibit 99.1 for any new corporate, clinical pipeline, or strategic information that could affect your view of the company.
• Because this is a Regulation FD filing, the information has been made broadly available to the market rather than disclosed privately. Investors should check the full exhibit on SEC EDGAR or Sagimet’s investor relations page for details.